(Q58010156)

4

0 references

Lourdes Florensa

object named as

L Florensa

11

0 references

author name string

E Puigdecanet

1

0 references

B Espinet

2

0 references

J J Lozano

3

0 references

B Bellosillo

5

0 references

A Álvarez-Larrán

7

0 references

F Solé

8

0 references

S Serrano

9

0 references

C Besses

https://scigraph.springernature.com/pub.10.1038/leu.2008.112

10

0 references

publication date

15 May 2008

0 references

published in

Leukemia

0 references

volume

22

0 references

issue

7

0 references

page(s)

1368-1376

0 references

exact match

0 references

cites work

Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

JAK2V617F-negative ET patients do not display constitutively active JAK/STAT signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

JAK2 V617F mutation analysis in different myeloid lineages (granulocytes, platelets, CFU-MK, BFU-E and CFU-GM) in essential thrombocythemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Bioconductor: open software development for computational biology and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Robust classification modeling on microarray data using misclassification penalized posterior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Two different functions for CD44 proteins in human myelopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Gene expression analysis of BCR/ABL1-dependent transcriptional response reveals enrichment for genes involved in negative feedback regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

7 January 2021

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

7 January 2021

Implication of CD44 in adhesion-mediated overproduction of TGF-beta and IL-1 in monocytes from patients with bone marrow fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

7 January 2021

V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.112

7 January 2021